DBVT FY 2019 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$538M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M+14.8% YoY

Gross Profit

$15M100.0% margin

Operating Income

-$171M-1162.8% margin

Net Income

-$172M-1169.5% margin

EPS (Diluted)

$-26.40

Cash Flow

Operating Cash Flow

-$148M

Free Cash Flow

-$154M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$272M

Total Liabilities

$79M

Stockholders' Equity

$193M

Cash & Equivalents

$193M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$13M	+14.8%
Gross Profit	$15M	$13M	+14.8%
Operating Income	-$171M	-$190M	+10.0%
Net Income	-$172M	-$190M	+9.6%